Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuguru Hayashi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Digestive Diseases and Sciences|September 13, 2022
Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis CYuichi Honma, Michihiko Shibata, Kahori Morino, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2019
Effect of direct-acting antivirals on platelet-associated immunoglobulin G and thrombocytopenia in hepatitis C virus-related chronic liver diseaseYuichi Honma, Michihiko Shibata, Tsuguru Hayashi, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of AtezolizumabYuichi Honma, Michihiko Shibata, Tomonori Gohda, et al.
Plos One|April 1, 2017
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratioYasuyuki Komiyama, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Journal of Gastroenterology|November 28, 2015
Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascitesHiroyuki Nakanishi, Masayuki Kurosaki, Takanori Hosokawa, et al.
Plos One|February 13, 2016
Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric NeoplasmsHiroyuki Nakanishi, Masayuki Kurosaki, Yuka Takahashi, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Digestive Diseases and Sciences|September 13, 2022
Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis CYuichi Honma, Michihiko Shibata, Kahori Morino, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2019
Effect of direct-acting antivirals on platelet-associated immunoglobulin G and thrombocytopenia in hepatitis C virus-related chronic liver diseaseYuichi Honma, Michihiko Shibata, Tsuguru Hayashi, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of AtezolizumabYuichi Honma, Michihiko Shibata, Tomonori Gohda, et al.
Plos One|April 1, 2017
Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratioYasuyuki Komiyama, Masayuki Kurosaki, Hiroyuki Nakanishi, et al.
Liver Cancer|October 27, 2016
Novel Pretreatment Scoring Incorporating C-reactive Protein to Predict Overall Survival in Advanced Hepatocellular Carcinoma with Sorafenib TreatmentHiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya, et al.
Journal of Gastroenterology|November 28, 2015
Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascitesHiroyuki Nakanishi, Masayuki Kurosaki, Takanori Hosokawa, et al.
Plos One|February 13, 2016
Pretreatment Gastric Lavage Reduces Postoperative Bleeding after Endoscopic Submucosal Dissection for Gastric NeoplasmsHiroyuki Nakanishi, Masayuki Kurosaki, Yuka Takahashi, et al.
Journal of Gastroenterology and Hepatology|April 25, 2019
Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarateShun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki, et al.
Plos One|August 16, 2016
Correction: Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular CarcinomaYutaka Yasui, Tokiya Abe, Masayuki Kurosaki, et al.
Pageof 3